Trial reportTranslational psychiatry2026
The Immediate and sustained benefits of two-week high-frequency aerobic exercise on depressive symptoms and frontal function in subthreshold depression: A randomized controlled trial.
Trial report in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aerobic exercise (AE) has been shown to improve subthreshold depression (SD). Current interventions typically involve longer durations and a moderate frequency. There is potential to further optimize this approach. This study designed a two-week high-frequency AE program and evaluated its efficacy and neural mechanisms in SD. This single-blind, randomized controlled study randomly assigned 57 female SD participants to AE (n = 29; 6-7 sessions/week) or a sitting control (n = 28). Depression severity and symptoms were assessed using the Beck Depression Inventory-II (BDI-II) and the Patient Health Questionnaire-9 (PHQ-9) at baseline, post-intervention, and two-week follow-up. Functional near-infrared spectroscopy combined with the Verbal Fluency Task was used to assess multiple neural activity metrics in the prefrontal cortex and motor cortex. The AE intervention significantly decreased in BDI-II and PHQ-9 scores, while increasing response and remission rates. Simultaneously, AE significantly reduced activation in the dorsolateral prefrontal cortex (DLPFC), frontal eye field (FEF), and premotor and supplementary motor areas (PMC-and-SMA). Functional connectivity strength decreased between the DLPFC and the FEF, PMC-and-SMA, and the primary somatosensory cortex (S1), and the PMC-and-SMA and S1. Network efficiency improved within the S1 and FEF, including enhanced node efficiency, increased degree centrality, and reduced shortest path. Moreover, the functional enhancement of PMC-and-SMA and FEF was significantly associated with alleviations in somatic symptoms (sleep disturbances and fatigue). The study demonstrates the feasibility and efficacy of the two-week high-frequency AE protocol in improving SD, with benefits comparable to those of previous AE protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.